Importantly, there were no worrying data about adverse events
The analysis on the respective cohorts was based on the following safety outcomes over 5 years from drug initiation: DKA, hypoglycaemia requiring admission to secondary care, urinary tract infection (UTI), pyelonephritis, candidiasis of the lower genital tract, acute pancreatitis and gastrointestinal upset
When combined, testosterone protects and builds muscle while GLP-1 medications drive fat loss
Then vegetables
282: G470-479
[DOI] [PMC free article] [PubMed] [Google Scholar] 134.Brnden A., Christensen M.B., Glintborg D., Snorgaard O., Kofoed-Enevoldsen A., Madsen G.K., Toft K., Kristensen J.K., Hjlund K., Hansen T.K., et al